欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IT/V/0112/001
药品名称DALMARELIN
活性成分
    • [No Active-Substance specified] 0.0 -
剂型Solution for injection
上市许可持有人Fatro S.p.A. Via Emilia, 285 Ozzano Emilia (BO) Italia
参考成员国 - 产品名称Italy (IT)
互认成员国 - 产品名称
    • Belgium (BE)
      Dalmarelin 25 µg/ml
    • Malta (MT)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Sweden (SE)
    • Slovenia (SI)
    • Norway (NO)
    • Slovakia (SK)
    • Poland (PL)
    • Hungary (HU)
    • Germany (DE)
      Dalmarelin
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
      Dalmarelin 25 microgram/ml Solution for Injection
    • Austria (AT)
    • France (FR)
      REPRORELINE 25 µG/ML SOLUTION INJECTABLE
    • Spain (ES)
    • Portugal (PT)
    • Finland (FI)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Denmark (DK)
    • Croatia (HR)
许可日期2003/10/29
最近更新日期2024/04/15
药物ATC编码
    • A ALIMENTARY TRACT AND METABOLISM
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full Dossier (art.5)
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase